Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ANDREW D ZELENETZ

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1841261351
CMS profile
83956
Location
NEW YORK, NY

General Payments · PY2018–2024

$267,869.50

  • Reported across 216 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$26,934.53

29 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Ipsen Biopharmaceuticals, Inc $18,061.22 11
Acerta Pharma LLC $2,670.14 4
BeiGene USA, Inc. $2,531.76 3
Celgene Corporation $2,100.00 1
ABBVIE INC. $750.00 1
TAIHO ONCOLOGY, INC. $374.15 4
Genmab U.S., Inc. $310.76 3
E.R. Squibb & Sons, L.L.C. $79.00 1
Kite Pharma, Inc. $57.50 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $37,697.91 36
PY2019 $45,065.99 44
PY2020 $52,501.65 21
PY2021 $25,937.61 14
PY2022 $41,705.58 27
PY2023 $38,026.23 45
PY2024 $26,934.53 29

Payment records · PY2024 (29)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $750.00 08/08/2024 Consulting Fee Undisputed 01/23/2026 1106393085 CMS
AstraZeneca Pharmaceuticals LP $163.04 07/23/2024 Compensation for serving as faculty or as a speaker for a medical education program Undisputed 01/23/2026 1105244069 CMS
AstraZeneca Pharmaceuticals LP $2,055.00 08/01/2024 Consulting Fee Undisputed 01/23/2026 1105779378 CMS
AstraZeneca Pharmaceuticals LP $406.98 09/30/2024 Compensation for serving as faculty or as a speaker for a medical education program Undisputed 01/23/2026 1104226763 CMS
AstraZeneca Pharmaceuticals LP $45.12 09/30/2024 Food and Beverage Undisputed 01/23/2026 1104570158 CMS
BeiGene USA, Inc. $243.02 02/09/2024 Food and Beverage Undisputed 01/23/2026 1120858329 CMS
BeiGene USA, Inc. $2,250.00 04/04/2024 Consulting Fee Undisputed 01/23/2026 1120858327 CMS
BeiGene USA, Inc. $38.74 04/06/2024 Food and Beverage Undisputed 01/23/2026 1120858325 CMS
Celgene Corporation $2,100.00 03/12/2024 Consulting Fee Undisputed 01/23/2026 1101132602 CMS
E.R. Squibb & Sons, L.L.C. $79.00 12/06/2024 Food and Beverage Undisputed 01/23/2026 1101416717 CMS
Genmab U.S., Inc. $187.50 07/15/2024 Consulting Fee Undisputed 01/23/2026 1126824272 CMS
Genmab U.S., Inc. $35.71 11/25/2024 Food and Beverage Undisputed 01/23/2026 1126824268 CMS
Genmab U.S., Inc. $87.55 12/08/2024 Food and Beverage Undisputed 01/23/2026 1126824270 CMS
Ipsen Biopharmaceuticals, Inc $3,480.00 05/31/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1091991413 CMS
Ipsen Biopharmaceuticals, Inc $6,090.00 09/14/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1091991415 CMS
Ipsen Biopharmaceuticals, Inc $195.34 09/14/2024 Travel and Lodging Undisputed 01/23/2026 1091991417 CMS
Ipsen Biopharmaceuticals, Inc $189.00 09/14/2024 Travel and Lodging Undisputed 01/23/2026 1091991419 CMS
Ipsen Biopharmaceuticals, Inc $308.04 09/14/2024 Travel and Lodging Undisputed 01/23/2026 1091991421 CMS
Ipsen Biopharmaceuticals, Inc $294.19 09/14/2024 Food and Beverage Undisputed 01/23/2026 1091991433 CMS
Ipsen Biopharmaceuticals, Inc $214.77 11/16/2024 Travel and Lodging Undisputed 01/23/2026 1091991423 CMS
Ipsen Biopharmaceuticals, Inc $265.53 11/16/2024 Travel and Lodging Undisputed 01/23/2026 1091991425 CMS
Ipsen Biopharmaceuticals, Inc $6,525.00 11/16/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1091991427 CMS
Ipsen Biopharmaceuticals, Inc $263.88 11/16/2024 Food and Beverage Undisputed 01/23/2026 1091991429 CMS
Ipsen Biopharmaceuticals, Inc $235.47 11/16/2024 Travel and Lodging Undisputed 01/23/2026 1091991431 CMS
Kite Pharma, Inc. $57.50 09/20/2024 Food and Beverage Undisputed 01/23/2026 1128609739 CMS
TAIHO ONCOLOGY, INC. $97.83 07/23/2024 Compensation for serving as faculty or as a speaker for a medical education program Undisputed 01/23/2026 1137941798 CMS
TAIHO ONCOLOGY, INC. $25.30 09/30/2024 Food and Beverage Undisputed 01/23/2026 1137935733 CMS
TAIHO ONCOLOGY, INC. $228.26 09/30/2024 Compensation for serving as faculty or as a speaker for a medical education program Undisputed 01/23/2026 1137941800 CMS
TAIHO ONCOLOGY, INC. $22.76 10/31/2024 Compensation for serving as faculty or as a speaker for a medical education program Undisputed 01/23/2026 1137940346 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.